Technology
Here’s Why Pfizer and BioNTech Are Selling Their Vaccine at Cost – Motley Fool
The humanitarian move might help the companies gain additional for-profit contracts in the future.
Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) recently agreed to sell their COVID-19 vaccine to the U.S. government at cost. In this video from Motley Fool Live, recorded on June 14, Fool.com contributors Brian Orelli and Keith Speights discuss why the companies…
Continue Reading
-
General16 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
Noosa News23 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
General21 hours agoRescuers pull children from the rubble of Indonesian boarding school collapse
-
Noosa News23 hours ago‘The Book of Mormon’ Returns to Melbourne and Brisbane in 2026